A surge in cases of Guillain-Barre Syndrome (GBS) in Peru has brought forward concerns over the links between the coronavirus (COVID-19) and the rare neurological disorder.
- The syndrome was among the prolonged neurological issues, known as long COVID complications, reported around the world following the onset of the COVID-19 pandemic.
About Guillain-Barré syndrome (GBS)
- Guillain-Barré syndrome (GBS) is a rare condition in which a person’s immune system attacks the peripheral nerves.
- People of all ages can be affected, but it is more common in adults and in males.
- Most people recover fully from even the most severe cases of Guillain-Barré syndrome.
- Severe cases of Guillain-Barré syndrome are rare, but can result in near-total paralysis.
- Guillain-Barré syndrome is potentially life-threatening. People with Guillain-Barré syndrome should be treated and monitored; some may need intensive care.
- Treatment includes supportive care and some immunological therapies.
- Guillain-Barré syndrome is often preceded by an infection. This could be a bacterial or viral infection. Guillain-Barré syndrome may also be triggered by vaccine administration or surgery.
